Article
For John Bingner Lyman, MD, time spent in his wood shop is just plane fun.
4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment
ROP: Treating and preventing blindness in preterm babies
Early vision screening is key to slowing myopia progression in children
Managing a changing landscape of IRD pediatric cases
Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
Cerebral visual impairment is a growing concern in pediatric vision loss
